Pharmaceutical company ranking based on R&D for developing countries in 2016*

Pharma company ranking based on R&D for developing countries 2016 This statistic depicts a pharmaceutical company ranking based on R&D for developing countries in 2016, according to the Access to Medicine Index 2016. In that year, the leading company concerning research and development for these markets was GlaxoSmithKline with an indicator score of 3.6 points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more
Loading statistic...
Expand statistic
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc3.6
Merck KGaA3.4
Johnson & Johnson3.3
Sanofi3.2
Novartis AG3.2
AbbVie Inc.3
Takeda Pharmaceutical Co.2.8
Eisai Co. Ltd.2.6
Daiichi Sankyo Co. Ltd.2.6
AstraZeneca plc2.6
Merck & Co. Inc.2.2
Bayer AG2.2
Boehringer-Ingelheim GmbH2
Pfizer Inc.1.8
Novo Nordisk A/S1.8
Gilead Sciences Inc.1.6
Astellas Pharma Inc.1.6
Eli Lilly & Co.1.5
Roche Holding Ltd1.4
Bristol-Myers Squibb Co.1.3
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc3.6
Merck KGaA3.4
Johnson & Johnson3.3
Sanofi3.2
Novartis AG3.2
AbbVie Inc.3
Takeda Pharmaceutical Co.2.8
Eisai Co. Ltd.2.6
Daiichi Sankyo Co. Ltd.2.6
AstraZeneca plc2.6
Merck & Co. Inc.2.2
Bayer AG2.2
Boehringer-Ingelheim GmbH2
Pfizer Inc.1.8
Novo Nordisk A/S1.8
Gilead Sciences Inc.1.6
Astellas Pharma Inc.1.6
Eli Lilly & Co.1.5
Roche Holding Ltd1.4
Bristol-Myers Squibb Co.1.3
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts a pharmaceutical company ranking based on R&D for developing countries in 2016, according to the Access to Medicine Index 2016. In that year, the leading company concerning research and development for these markets was GlaxoSmithKline with an indicator score of 3.6 points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more
Release date
November 2016
Region
Worldwide
Survey time period
2016
Supplementary notes
* The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom

Related Studies: Available to Download in PDF or PPTX Format

Monsanto-Bayer
Monsanto-Bayer

All Information
in one Presentation

Monsanto-Bayer

Everything On "Monsanto-Bayer" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Johnson & Johnson"

  • Key Figures
  • Johnson & Johnson's Impact on the Pharmaceutical Market
The most important statistics
  • Johnson & Johnson's Impact on the Medical Devices & Diagnostic Market
  • Johnson & Johnson's Impact on the Cosmetic Market
  • Forecasts
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News